| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 104-98-3 | 尿刊酸; 4-咪唑丙烯酸 | Urocanic acid; 4-Imidazoleacrylic acid; 3-(4-Imidazolyl)acrylic acid |  | C6H6N2O2 | 詳情 | 供應商 |
| 120-93-4 | 2-咪唑烷酮; 乙烯脲; 環(huán)亞乙烯脲 | Ethyleneurea; 2-Imidazolidinone; 2-Imidazolidone |  | C3H6N2O | 詳情 | 供應商 |
| 1072-63-5 | 1-乙烯基咪唑 | Vinylimidazole; 1-Vinylimidazole |  | C5H6N2 | 詳情 | 供應商 |
| 4342-03-4 | 達卡巴嗪; 5-(3,3-二甲基-1-三氮烯)咪唑-4-羧酰胺; 氮烯咪胺 | Dacarbazine; 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide; 4-(3,3-Dimethyltriazeno)imidazole-5-carboxamide; 4-(Dimethyltriazeno)imidazole-5-carboxamide |  | C6H10N6O | 詳情 | 供應商 |
| 31410-01-2 | N-烯丙基咪唑 | 1-Allylimidazole; 1-Allyl-1H-imidazole |  | C6H8N2 | 詳情 | 供應商 |
| 33586-66-2 | 抑霉唑硝酸鹽; 1-(2-(2,4-二氯苯基)-2-(2-烯丙氧基)乙基)-1H-咪唑硝酸鹽 | Imazalil nitrate; 1-(2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl)-1H-imidazole mononitrate |  | C14H14Cl2N2O.HNO3 | 詳情 | 供應商 |
| 35554-44-0 | 抑霉唑; 1-(beta-烯丙氧基-beta-2,4-二氯苯乙基)咪唑; 1-[2-(2,4-二氯苯基)-2-(2-烯丙氧基)乙基]-1H-咪唑 | Imazalil; 1-[2-(2,4-Dichloro-phenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole; 1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole |  | C14H14Cl2N2O | 詳情 | 供應商 |
| 58594-72-2 | 抑霉唑硫酸鹽; 1-[2-(烯丙氧基)乙基-2-(2,4-二氯苯基)]-1H-咪唑硫酸鹽 | Imazalil sulfate; 1-[2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate (1:1) |  | C14H14Cl2N2O.H2SO4 | 詳情 | 供應商 |
| 77174-66-4 | 鹽酸氯康唑; 1-[1-[2-[(3-氯苯基)甲氧基]苯基]乙烯基]咪唑鹽酸鹽 | Croconazole hydrochloride; 1-[1-[2-[(3-Chlorophenyl)methoxy]phenyl]ethenyl]imidazole hydrochloride |  | C18H16Cl2N2O | 詳情 | 供應商 |
| 78712-43-3 | 鹽酸奧扎格雷; 反式-3-[4-(1H-咪唑-1-甲基)苯基]-2-丙烯酸鹽酸鹽 | Ozagrel hydrochloride; (E)-3-(4-(1H-Imidazol-1-ylmethyl)phenyl)-2-propenoic acid hydrochloride |  | C13H13ClN2O2 | 詳情 | 供應商 |
| 82571-53-7 | 奧扎格雷; 反式-3-[4-(1H-咪唑-1-基甲基)苯基]-2-丙烯酸 | Ozagrel; (E)-3-[4-(1H-Imidiazol-1-ylmethyl)phenyl]-2-propenic acid |  | C13H12N2O2 | 詳情 | 供應商 |
| 85622-93-1 | 替莫唑胺; 4-甲基-5-氧代-2,3,4,6,8-五氮雜雙環(huán)[4.3.0]壬-2,7,9-三烯-9-甲酰胺; 3,4-二氫-3-甲基-4-氧代咪唑? | Temozolomide; 4-Methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide |  | C6H6N6O2 | 詳情 | 供應商 |
| 121325-67-5 | 2-咪唑啉酮半水合物; 亞乙基脲半水合物; 乙烯脲半水合物 | 2-Imidazolidone hemihydrate; 2-Imidazolidinone hemihydrate; Ethylene urea hemihydrate |  | 2(C3H6N2O).H2O | 詳情 | 供應商 |
| 128326-82-9 | 依柏康唑; (+/-)-1-(2,4-二氯-10,11-二氫-5H-二苯并[a,d]環(huán)庚烯-5-基)咪唑 | Eberconazole; (+/-)-1-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)imidazole |  | C18H14Cl2N2 | 詳情 | 供應商 |
| 144143-96-4 | 甲磺酸依普羅沙坦; 4-[[2-丁基-5-(2-甲酰基-3-噻吩-2-基-丙烯-1-基)-咪唑-1-基]甲基]苯甲酸甲磺酸鹽 | Eprosartan mesylate; 4-[[2-Butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate |  | C24H28N2O7S2 | 詳情 | 供應商 |
| 144689-63-4 | 奧美沙坦酯; 2,3-二羥基-2-丁烯基-4-(1-羥基-1-甲基乙基)-2-丙基-1-[4-(2-1H-四唑-5-苯基)芐基]咪唑-5-羧酸? | Olmesartan medoxomil; Olmetec; CS-866; 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl ester |  | C29H30N6O6 | 詳情 | 供應商 |
| 144689-78-1 | 奧美沙坦酯; 2,3-二羥基-2-丁烯基-4-(1-羥基-1-甲基乙基)-2-丁基-1-[4-(2-1H-四唑-5-苯基)芐基]咪唑-5-羧酸? | Olmesartan; 2-Butyl-4-(1-hydroxy-1-methylethyl)-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester |  | C30H32N6O6 | 詳情 | 供應商 |
| 150599-70-5 | 聚季銨鹽-44; N-乙烯吡咯烷酮和季銨化乙烯咪唑共聚物 | Polyquaternium-44; L-Poly[(3-methyl-1-vinylimidazolium methyl sulfate)-co-(1-vinylpyrrolidone)]; 1-Methyl-3-vinylimidazolium methyl sulfate-N-vinyl-2-pyrrolidone copolymer |  | (C6H9N2)x.(C6H9NO)x.(CH3O4S)x | 詳情 | 供應商 |
| 166176-51-8 | 1-[[(6R,7R)-7-氨基-2-羧基-8-氧代-5-硫雜-1-氮雜雙環(huán)[4.2.0]辛-2-烯-3-基]甲基]咪唑并[1,2-b]噠嗪二鹽酸鹽 | 7-ACD; 1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]imidazo[1,2-b]pyridazinium chloride monohydrochloride |  | C14H14N5O3S.Cl.HCl | 詳情 | 供應商 |
| 189224-26-8 | 奧扎格雷鈉; 反式-3-[4-(1H-咪唑-1-甲基)苯基]-2-丙烯酸鈉 | Ozagrel sodium; (2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic acid sodium salt |  | C13H11N2NaO2 | 詳情 | 供應商 |